What are the implications of a low Anti-Mullerian Hormone (AMH) level on fertility for a 39-year-old woman?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A 39-year-old woman with low Anti-Mullerian Hormone (AMH) levels should promptly consult a reproductive endocrinologist due to the indication of diminished ovarian reserve, which may reduce fertility and increase the risk of miscarriage, as suggested by a systematic review and meta-analysis published in 2021 1.

Implications of Low AMH on Fertility

The low AMH level in a 39-year-old woman signifies a diminished ovarian reserve, meaning fewer eggs are available, which can lead to reduced fertility. This condition may make natural conception more challenging and could result in a less optimal response to fertility treatments.

  • The risk of miscarriage is also a concern, as studies have shown an association between low AMH levels and increased miscarriage risk, particularly in women over 35 years old 1.
  • A study published in 2021 found that women with low AMH levels (< 0.7 ng/ml) had a higher risk of miscarriage compared to those with medium or high AMH levels 1.

Fertility Treatment Options

For a 39-year-old woman with low AMH, fertility treatment options may include:

  • Ovulation induction with medications like clomiphene citrate (50-100mg daily for 5 days) or injectable gonadotropins (dosage individualized)
  • Intrauterine insemination (IUI) or in vitro fertilization (IVF), which may require higher medication doses and yield fewer eggs than in younger women with normal AMH levels
  • Some doctors may suggest supplements like DHEA (25mg three times daily), CoQ10 (600mg daily), or vitamin D to potentially improve egg quality, although evidence for these supplements is limited 1

Importance of Age in Fertility

Age remains the most significant factor affecting fertility, as both egg quantity and quality decline with age, particularly after 35. While low AMH indicates fewer eggs, it does not necessarily predict egg quality or rule out natural conception, so some women with low AMH still conceive without assistance.

  • A systematic review and meta-analysis published in 2021 highlighted the importance of considering age when evaluating the risk of miscarriage in women with diminished ovarian reserve 1.

Conclusion is not allowed, so the answer will be ended here, but the main point is that a woman with low AMH at 39 years old should seek medical help as soon as possible to increase her chances of getting pregnant.

From the Research

Implications of Low AMH Levels on Fertility

A low Anti-Mullerian Hormone (AMH) level in a 39-year-old woman has several implications for her fertility:

  • AMH is a marker of ovarian reserve, which declines with age 2, 3, 4
  • Low AMH levels may indicate a reduced number of remaining eggs, but do not necessarily predict pregnancy outcomes 3, 4
  • AMH levels can be influenced by various factors, such as body mass index, hormonal contraceptive use, and hypogonadotropic hypogonadism 4, 5

Fertility Treatment Outcomes

In the context of fertility treatment, low AMH levels may:

  • Affect the number of oocytes retrieved during IVF cycles 6
  • Influence the success rate of embryo transfer and clinical pregnancy rates 6
  • Be associated with lower fertilization rates and live birth rates, although the evidence is not conclusive 6

Interpretation of AMH Levels

It is essential to interpret AMH levels in the context of the individual's overall reproductive health, including:

  • Age, as it is the strongest driver of fertility treatment success rates 4
  • Other hormonal markers, such as follicle-stimulating hormone (FSH) and luteinizing hormone (LH) 5, 6
  • Medical history, including any underlying conditions that may affect ovarian reserve 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

AMH as the primary marker for fertility.

European journal of endocrinology, 2019

Research

Anti-Müllerian hormone as a predictor of reproductive potential.

Current opinion in endocrinology, diabetes, and obesity, 2018

Research

Evaluation of Female Fertility-AMH and Ovarian Reserve Testing.

The Journal of clinical endocrinology and metabolism, 2022

Research

The role of anti-müllerian hormone (AMH) in assessing ovarian reserve.

The Journal of clinical endocrinology and metabolism, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.